» Articles » PMID: 37755462

Correlation of Glymphatic System Abnormalities with Parkinson's Disease Progression: a Clinical Study Based on Non-invasive FMRI

Overview
Journal J Neurol
Specialty Neurology
Date 2023 Sep 27
PMID 37755462
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The glymphatic system is reportedly involved in Parkinson's disease (PD). Based on previous studies, we aimed to confirm the correlation between the glymphatic system and PD progression by combining two imaging parameters, diffusion tensor image analysis along the perivascular space (DTI-ALPS), and enlarged perivascular spaces (EPVS).

Methods: Fifty-one PD patients and fifty healthy control (HC) were included. Based on the Hoehn-Yahr scale, the PD group was divided into early-stage and medium-to late-stage. All PD patients were scored using the Unified PD Rating Scale (UPDRS). We assessed the DTI-ALPS indices in the bilateral hemispheres and EPVS numbers in bilateral centrum semiovale (CSO), basal ganglia (BG), and midbrain.

Results: The DTI-ALPS indices were significantly lower bilaterally in PD patients than in the HC group, and EPVS numbers in any of the bilateral CSO, BG, and midbrain were significantly higher, especially for the medium- to late-stage group and the BG region. In PD patients, the DTI-ALPS index was significantly negatively correlated with age, while the BG-EPVS numbers were significantly positively correlated with age. Furthermore, the DTI-ALPS index was negatively correlated with UPDRS II and III scores, while the BG-EPVS numbers were positively correlated with UPDRS II and III scores. Similarly, the correlation was more pronounced in the medium- to late-stage group.

Conclusion: The DTI-ALPS index and EPVS numbers (especially in the BG region) are closely related to age and PD progression and can serve as non-invasive assessments for glymphatic dysfunction and its interventions in clinical studies.

Citing Articles

Diffusion tensor image analysis along the perivascular space and quantitative susceptibility mapping in the diagnosis and severity assessment of Parkinson's disease.

Ni C, Chen L, Lin R, Zheng W, Cai Y, Cai G Quant Imaging Med Surg. 2025; 15(2):1411-1424.

PMID: 39995711 PMC: 11847189. DOI: 10.21037/qims-24-1605.


Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.

Ren J, Xie D, Wang L, Wu Z, Lin S, Jin Q J Neurol. 2025; 272(3):196.

PMID: 39932513 DOI: 10.1007/s00415-025-12944-1.


Assessment of glymphatic function and white matter integrity in children with autism using multi-parametric MRI and machine learning.

Wang M, He K, Zhang L, Xu D, Li X, Wang L Eur Radiol. 2025; 35(3):1623-1636.

PMID: 39843628 DOI: 10.1007/s00330-025-11359-w.


Genome-wide association study unravels mechanisms of brain glymphatic activity.

Huang S, Ge Y, Ren P, Wu B, Gong W, Du J Nat Commun. 2025; 16(1):626.

PMID: 39805841 PMC: 11730627. DOI: 10.1038/s41467-024-55706-9.


Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer's and Parkinson's diseases.

Costa T, Manuello J, Premi E, Mattioli I, Lasagna L, Lahoz C Sci Rep. 2024; 14(1):26381.

PMID: 39487289 PMC: 11530450. DOI: 10.1038/s41598-024-78132-9.


References
1.
Keir L, Breen D . New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease. J Neurol. 2019; 267(1):288-294. PMC: 6954899. DOI: 10.1007/s00415-019-09651-z. View

2.
Atik A, Stewart T, Zhang J . Alpha-Synuclein as a Biomarker for Parkinson's Disease. Brain Pathol. 2016; 26(3):410-8. PMC: 6245641. DOI: 10.1111/bpa.12370. View

3.
Mehra S, Sahay S, Maji S . α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis. Biochim Biophys Acta Proteins Proteom. 2019; 1867(10):890-908. DOI: 10.1016/j.bbapap.2019.03.001. View

4.
Tolosa E, Garrido A, Scholz S, Poewe W . Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021; 20(5):385-397. PMC: 8185633. DOI: 10.1016/S1474-4422(21)00030-2. View

5.
Reich S, Savitt J . Parkinson's Disease. Med Clin North Am. 2019; 103(2):337-350. DOI: 10.1016/j.mcna.2018.10.014. View